Description
Respiratory syncytial virus stock is produced by cell culture and formulated with purified, intact viral particles. The virus particles have been chemically modified to render them non-infectious and refrigerator stable. The inactivation was verified in a standard microbiological growth protocol. RSV stock can be used in the development of RSV diagnostics and in vaccine development and R&D.